600 related articles for article (PubMed ID: 24292552)
1. New viruses for cancer therapy: meeting clinical needs.
Miest TS; Cattaneo R
Nat Rev Microbiol; 2014 Jan; 12(1):23-34. PubMed ID: 24292552
[TBL] [Abstract][Full Text] [Related]
2. Introduction to Oncolytic Virotherapy.
Engeland CE; Bell JC
Methods Mol Biol; 2020; 2058():1-6. PubMed ID: 31486028
[TBL] [Abstract][Full Text] [Related]
3. Optimization and preclinical design of genetically engineered viruses for human oncolytic therapy.
Hiss DC; Fielding BC
Expert Opin Biol Ther; 2012 Nov; 12(11):1427-47. PubMed ID: 22788715
[TBL] [Abstract][Full Text] [Related]
4. Advanced new strategies for metastatic cancer treatment by therapeutic stem cells and oncolytic virotherapy.
Park GT; Choi KC
Oncotarget; 2016 Sep; 7(36):58684-58695. PubMed ID: 27494901
[TBL] [Abstract][Full Text] [Related]
5. Oncolytic viruses in the treatment of cancer: a review of current strategies.
Zeyaullah M; Patro M; Ahmad I; Ibraheem K; Sultan P; Nehal M; Ali A
Pathol Oncol Res; 2012 Oct; 18(4):771-81. PubMed ID: 22714538
[TBL] [Abstract][Full Text] [Related]
6. Development of oncolytic viruses for cancer therapy.
Abd-Aziz N; Poh CL
Transl Res; 2021 Nov; 237():98-123. PubMed ID: 33905949
[TBL] [Abstract][Full Text] [Related]
7. Clinical development directions in oncolytic viral therapy.
Eager RM; Nemunaitis J
Cancer Gene Ther; 2011 May; 18(5):305-17. PubMed ID: 21436867
[TBL] [Abstract][Full Text] [Related]
8. Virotherapy in Germany-Recent Activities in Virus Engineering, Preclinical Development, and Clinical Studies.
Nettelbeck DM; Leber MF; Altomonte J; Angelova A; Beil J; Berchtold S; Delic M; Eberle J; Ehrhardt A; Engeland CE; Fechner H; Geletneky K; Goepfert K; Holm PS; Kochanek S; Kreppel F; Krutzke L; Kühnel F; Lang KS; Marchini A; Moehler M; Mühlebach MD; Naumann U; Nawroth R; Nüesch J; Rommelaere J; Lauer UM; Ungerechts G
Viruses; 2021 Jul; 13(8):. PubMed ID: 34452286
[TBL] [Abstract][Full Text] [Related]
9. Design of virotherapy for effective tumor treatment.
Garcia-Aragoncillo E; Hernandez-Alcoceba R
Curr Opin Mol Ther; 2010 Aug; 12(4):403-11. PubMed ID: 20677091
[TBL] [Abstract][Full Text] [Related]
10. Oncolytic virotherapy as promising immunotherapy against cancer: mechanisms of resistance to oncolytic viruses.
Goradel NH; Alizadeh A; Hosseinzadeh S; Taghipour M; Ghesmati Z; Arashkia A; Negahdari B
Future Oncol; 2022 Jan; 18(2):245-259. PubMed ID: 34821517
[TBL] [Abstract][Full Text] [Related]
11. Current strategies of virotherapy in clinical trials for cancer treatment.
Lin W; Zhao Y; Zhong L
J Med Virol; 2021 Aug; 93(8):4668-4692. PubMed ID: 33738818
[TBL] [Abstract][Full Text] [Related]
12. Oncolytic virotherapy.
Cervantes-García D; Ortiz-López R; Mayek-Pérez N; Rojas-Martínez A
Ann Hepatol; 2008; 7(1):34-45. PubMed ID: 18376364
[TBL] [Abstract][Full Text] [Related]
13. [Current state of oncolytic virotherapy in Japan].
Nakamori M; Yamaue H
Gan To Kagaku Ryoho; 2013 May; 40(5):553-8. PubMed ID: 23863576
[TBL] [Abstract][Full Text] [Related]
14. [Genetic, immunological, and pharmacological strategies to generate improved oncolytic viruses].
Pol J; Le Bœuf F; Diallo JS
Med Sci (Paris); 2013 Feb; 29(2):165-73. PubMed ID: 23452603
[TBL] [Abstract][Full Text] [Related]
15. Integrating oncolytic viruses in combination cancer immunotherapy.
Bommareddy PK; Shettigar M; Kaufman HL
Nat Rev Immunol; 2018 Aug; 18(8):498-513. PubMed ID: 29743717
[TBL] [Abstract][Full Text] [Related]
16. Oncolytic Viruses for Systemic Administration: Engineering a Whole Different Animal.
Atasheva S; Shayakhmetov DM
Mol Ther; 2021 Mar; 29(3):904-907. PubMed ID: 33577782
[No Abstract] [Full Text] [Related]
17. Gene therapy progress and prospects cancer: oncolytic viruses.
Liu TC; Kirn D
Gene Ther; 2008 Jun; 15(12):877-84. PubMed ID: 18418413
[TBL] [Abstract][Full Text] [Related]
18. Virus combinations and chemotherapy for the treatment of human cancers.
Kumar S; Gao L; Yeagy B; Reid T
Curr Opin Mol Ther; 2008 Aug; 10(4):371-9. PubMed ID: 18683102
[TBL] [Abstract][Full Text] [Related]
19. History of how viruses can fight cancer: From the miraculous healings to the approval of oncolytic viruses.
Bifulco M; Di Zazzo E; Napolitano F; Malfitano AM; Portella G
Biochimie; 2023 Mar; 206():89-92. PubMed ID: 36273765
[TBL] [Abstract][Full Text] [Related]
20. Oncolytic virotherapy: Challenges and solutions.
Goradel NH; Baker AT; Arashkia A; Ebrahimi N; Ghorghanlu S; Negahdari B
Curr Probl Cancer; 2021 Feb; 45(1):100639. PubMed ID: 32828575
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]